Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHLOROBRAIN: Chloroquine with Chemoradiation for Glioblastoma
NCT02378532Phase 1Completed
- Sponsor
- Maastro Clinic
- Start
- Aug 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of chloroquine in glioblastoma (GBM), sponsored by Maastro Clinic. Primary endpoint: Toxicity (CTC AE 4.0) up to 2.5 years. Started Aug 2016; status: completed.
02
Drugs
chloroquine
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT02378532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02378532.